Vanderbilt University Medical Center (VUMC) is committed to excellence in patient care, leadership in research, and preeminence in medical education. Our culture thrives on challenges and champions innovation, while striving to make healthcare personal.
Connect with us:
February 04, 2022
Video
The assistant clinical professor at Vanderbilt University School of Medicine discussed ways of incorporating and encouraging women physicians to enter the neurology specialty. [WATCH TIME: 4 minutes]
February 03, 2022
Video
The assistant clinical professor at Vanderbilt University School of Medicine shared what National Women Physicians Day means to her, and the history behind its celebration. [WATCH TIME: 6 minutes]
January 30, 2022
Article
After discontinuing dosing in the phase 3 GENERATION HD1 study in 2021, Roche is designing a new phase 2 trial for tominersen, its investigational antisense oligomer for Huntington disease.
January 20, 2022
Article
After a post hoc analysis revealed promising results in a subgroup of younger adults with less disease burden, Ionis has announced that Roche will develop a new phase 2 trial.
December 08, 2021
Article
The FDA has previously granted the Acadia Pharmaceuticals treatment fast track status and orphan drug designation for Rett syndrome.
June 14, 2021
Article
Despite a few surprising program failures early this year, there is plenty of potential worth holding on to in the Huntington disease pipeline.
The Mobile Stroke Unit Paradigm Shift for EMS: Thomas Topley
American Stroke Association Publishes Updated Guidance for Intracerebral Hemorrhage
FDA Accepts New Drug Application for Intranasal Zavegepant to Treat Acute Migraine
Tackling Neurodegeneration in Multiple Sclerosis: Emily Harrington, MD, PhD